ESCO2 promotes lung adenocarcinoma progression by regulating hnRNPA1 acetylation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ESCO2 promotes lung adenocarcinoma progression by regulating hnRNPA1 acetylation
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 40, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-11
DOI
10.1186/s13046-021-01858-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Establishment of cohesion 1 homolog 2 facilitates cell aggressive behaviors and induces poor prognosis in renal cell carcinoma
- (2020) Qiu‐Li Wang et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Targeted Therapy for Non-Small Cell Lung Cancer
- (2020) Zorawar S. Noor et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- MEK or ERK inhibition effectively abrogates emergence of acquired osimertinib resistance in the treatment of epidermal growth factor receptor–mutant lung cancers
- (2020) Jiajia Gu et al. CANCER
- Optimal Management of Patients with Advanced NSCLC Harboring High PD-L1 Expression and Driver Mutations
- (2020) Justin A. Chen et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Molecular therapeutic targets in non-small cell lung cancer
- (2020) Kamya Sankar et al. Expert Review of Anticancer Therapy
- Key prognostic factors for EGFR-mutated non-adenocarcinoma lung cancer patients in the Japanese Joint Committee of Lung Cancer Registry Database
- (2020) Keigo Kobayashi et al. LUNG CANCER
- Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells
- (2020) Yvette Robbins et al. eLife
- Adenocarcinoma of the lung: from BAC to the future
- (2020) Gerard Lambe et al. Insights into Imaging
- Sirtuin-mediated deacetylation of hnRNP A1 suppresses glycolysis and growth in hepatocellular carcinoma
- (2019) Hao Yang et al. ONCOGENE
- Computer-Aided Discovery of Small Molecules Targeting the RNA Splicing Activity of hnRNP A1 in Castration-Resistant Prostate Cancer
- (2019) Lavinia Carabet et al. MOLECULES
- ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer
- (2019) Alice T. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome wide analysis of hnRNP binding to HIV-1 RNA reveals a key role for hnRNP H1 in alternative viral mRNA splicing
- (2019) Sebla B. Kutluay et al. JOURNAL OF VIROLOGY
- Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway
- (2019) Hui-er Zhu et al. Cell Death & Disease
- ESCO2 knockdown inhibits cell proliferation and induces apoptosis in human gastric cancer cells
- (2018) Hongmei Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Identification of methylation sites and signature genes with prognostic value for luminal breast cancer
- (2018) Bin Xiao et al. BMC CANCER
- Organ-Specific MicroRNAs (MIR122, 137, and 206) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (PKM) Expression
- (2018) Kohei Taniguchi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis
- (2018) Xiaoyue Zhao et al. Scientific Reports
- Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
- (2018) Ugo Testa et al. Cancers
- SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells
- (2018) Yuki Kuranaga et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ESCO2 inhibits tumor metastasis via transcriptionally repressing MMP2 in colorectal cancer
- (2018) Xiong-Bo Guo et al. Cancer Management and Research
- Molecular biomarkers for lung adenocarcinoma
- (2017) Olivier Calvayrac et al. EUROPEAN RESPIRATORY JOURNAL
- A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth
- (2017) Jin-Zhou Huang et al. MOLECULAR CELL
- Esco1 and Esco2 regulate distinct cohesin functions during cell cycle progression
- (2017) Reem M. Alomer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metabolic phenotype of bladder cancer
- (2016) Francesco Massari et al. CANCER TREATMENT REVIEWS
- Oral squamous cancer cell exploits hnRNP A1 to regulate cell cycle and proliferation
- (2015) Cheng Yu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Development and Validation of a Nomogram for Predicting Survival in Patients With Resected Non–Small-Cell Lung Cancer
- (2015) Wenhua Liang et al. JOURNAL OF CLINICAL ONCOLOGY
- Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells
- (2015) S Calabretta et al. ONCOGENE
- Cohesin recruits the Esco1 acetyltransferase genome wide to repress transcription and promote cohesion in somatic cells
- (2015) Sadia Rahman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HnRNP A1/A2 and SF2/ASF Regulate Alternative Splicing of Interferon Regulatory Factor-3 and Affect Immunomodulatory Functions in Human Non-Small Cell Lung Cancer Cells
- (2013) Rong Guo et al. PLoS One
- Concentration-dependent control of pyruvate kinase M mutually exclusive splicing by hnRNP proteins
- (2012) Mo Chen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Emerging roles of PKM2 in cell metabolism and cancer progression
- (2012) Weibo Luo et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- REST and CoREST are transcriptional and epigenetic regulators of seminal neural fate decisions
- (2010) Irfan A. Qureshi et al. CELL CYCLE
- HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
- (2009) Charles J. David et al. NATURE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started